The suit, filed May 6, further states that Express Scripts and UnitedHealth along with a number of each company’s pharmacy-benefit manager subsidiaries has “for no less than the last two decades … had a key role in facilitating the oversupply of opioids through intentional conduct, ignoring needed safeguards in order to increase the prescribing, dispensing, and sales of prescription opioids.”